Table 1.
Patient group characteristics
| tDCS | |
|---|---|
| Gender (male/female) | 7/9 |
| Age (mean ± SD), years | 42.8 ± 10.9 |
| HDRSa | |
| Baseline | 21.6 ± 3.9 |
| Week 3 | 14.3 ± 6.1 |
| Week 10 | 13.8 ± 10.1 |
| PA | |
| Baseline | 17.1 ± 6.3 |
| Week 3 | 21.5 ± 9.1 |
| Week 10 | 25.0 ± 11.4 |
| NA | |
| Baseline | 29.6 ± 9.3 |
| Week 3 | 26.4 ± 11.4 |
| Week 10 | 21.8 ± 10.1 |
| STAI—state | |
| Baseline | 54.6 ± 10.1 |
| Week 3 | 51.6 ± 13.4 |
| Week 10 | 48.3 ± 16.4 |
| STAI—trait | |
| Baseline | 65.6 ± 6.3 |
| Week 3 | 60.6 ± 11.5 |
| Week 10 | 54.3 ± 17.7 |
| Emean (V/m) | |
| DFLP—left | 0.317 ± 0.055 |
| DLFPC—right | 0.332 ± 0.059 |
| ACC—left | 0.153 ± 0.030 |
| ACC—right | 0.145 ± 0.030 |
Distribution of characteristics, clinical outcomes, and mean electric field strength of the four main analyzed regions. Values are displayed as mean ± standard deviation
HDRS Hamilton depression rating scale, PA positive affect, NA negative affect, STAI state–trait anxiety inventory, Emean Mean electric field strength inside ROI, DLPFC dorsolateral prefrontal cortex, ACC anterior cingulate cortex
a
Scores on the 17-item Hamilton depression rating scale (0–52, the higher the more severely depressed)